Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,802,826 entitled “Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume” by the United States Patent and Trademark Office (“USPTO”)
Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,802,826 entitled “Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume” by the United States Patent and Trademark Office (“USPTO”)